Akebia Therapeutics (AKBA) Prepaid Assets (2013 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Prepaid Assets of $3.6 million for Q1 2026, down 60.59% year-over-year from $9.1 million in Q1 2025, and down 34.17% quarter-over-quarter from $5.5 million in Q4 2025.
Akebia Therapeutics (AKBA) Prepaid Assets (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Prepaid Assets for 14 consecutive years, with $3.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 60.59% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $3.6 million (down 60.59% YoY), while the FY2025 annual figure was $5.5 million, down 51.81% from the prior year.
- Prepaid Assets declined to $3.6 million in Q1 2026 per AKBA's latest filing, from $5.5 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $42.1 million in Q2 2022 and bottomed at $3.6 million in Q1 2026.
- Historically, Prepaid Assets has averaged $16.9 million across 5 years, with a median of $13.4 million in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 276.79% — and 2023, when it slumped 82.49%.
- Akebia Therapeutics' Prepaid Assets stood at $32.9 million in 2022, then plunged by 82.49% to $5.8 million in 2023, then jumped by 97.25% to $11.4 million in 2024, then sank by 51.81% to $5.5 million in 2025, then slumped by 34.17% to $3.6 million in 2026.
- Business Quant data shows AKBA's Prepaid Assets at $3.6 million in Q1 2026, $5.5 million in Q4 2025, and $7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.48 Mn |
| Mar 31, 2026 | 3.60 Mn |
| Dec 31, 2025 | 5.47 Mn |
| Sep 30, 2025 | 7.03 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Mar 31, 2025 | 9.14 Mn |
| Dec 31, 2024 | 11.35 Mn |
| Sep 30, 2024 | 13.44 Mn |
| Jun 30, 2024 | 18.96 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | 5.75 Mn |
| Sep 30, 2023 | 22.04 Mn |
| Jun 30, 2023 | 24.40 Mn |
| Mar 31, 2023 | 24.70 Mn |
| Dec 31, 2022 | 32.86 Mn |
| Sep 30, 2022 | 28.94 Mn |
| Jun 30, 2022 | 42.13 Mn |
| Mar 31, 2022 | 24.12 Mn |
| Dec 31, 2021 | 33.14 Mn |
| Sep 30, 2021 | 39.50 Mn |